Status:
UNKNOWN
Multimodal Imaging Based on Pathological and Genomic Characteristics
Lead Sponsor:
Affiliated Hospital to Academy of Military Medical Sciences
Conditions:
Mitochondrial DNA Mutation
Endoscopy
Eligibility:
All Genders
18-80 years
Brief Summary
Mitochondrial DNA mutations in normal gastric tissue, early gastric cancer and advanced gastric cancer were identified by single cell sequencing, and the origin of gastric stem cells was traced and ne...
Detailed Description
In this study, on the basis of previous work, aiming at the visualization of key molecular functions of gastric cancer, a full-chain digestive endoscopic diagnosis system was constructed by using cros...
Eligibility Criteria
Inclusion
- Diagnosis or suspected diagnosis of one of the following common digestive mucosal diseases: gastritis, gastric cancer, colorectal polyps, bowel cancer
- Written informed consent
Exclusion
- Patients with cardiovascular and cerebrovascular diseases, or patients with severe impairment of liver, kidney and hematopoietic system
- Mental patients
- Hemorrhagic diseases
- Platelet count \< 50 × 10 \^ 9 / L
- Allergic constitution
- unable to tolerate or cooperate with endoscopy
- Patients with serious complications, such as intestinal obstruction, intestinal perforation, toxic colonic dilatation, colorectal cancer, etc.
- Pregnant or lactating women
Key Trial Info
Start Date :
March 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05196243
Start Date
March 21 2022
End Date
July 1 2024
Last Update
April 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Medical Center of Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853